QS Batterymarch Financial Management’s Amicus Therapeutics FOLD Stock Holding History

QS Batterymarch Financial Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.28M	Buy	+215,518	New	+$1.13M	0.03%	486

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

QS Batterymarch Financial Management's FOLD Position: Q3 2014 in Review

QS Batterymarch Financial Management opened a new position in Amicus Therapeutics (FOLD) in Q3 2014: 215,518 shares worth $1.28M. The stake represents 0.03% of the portfolio and ranks #486 among its holdings.

95 funds tracked by Wall St. Rank hold FOLD as of Q3 2014.

QS Batterymarch Financial Management held 215,518 shares of Amicus Therapeutics worth $1.28M as of Q3 2014.
Amicus Therapeutics was a new QS Batterymarch Financial Management position in Q3 2014.
Amicus Therapeutics made up 0.03% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #486 holding.
95 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.